Finding markers in HPV-related throat cancer to guide treatment
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks for certain markers in people with HPV-related throat cancer that could help doctors choose the best treatment. If you are planning to have surgery for your throat cancer, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of throat cancer called oropharyngeal squamous cell carcinoma (cancer in the back of the throat).
- You are older than 18 years old.
- You are healthy enough to do most daily activities (your doctor will check this with a simple scale).
- You are willing to sign a consent form to join the study and allow your data to be used.
- Your cancer has not spread to other parts of your body (like the lungs or liver).
- You have not had head and neck cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a blood test that finds DNA from HPV-related throat tumors. It may help doctors decide on surgery and check if the cancer is completely removed.
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
This observational study checks how well a blood test for HPV DNA (and other tumor genetic markers) predicts outcomes in certain throat cancers. It may help doctors better track the disease and plan treatment, because the trial validates these lab signals against real-world results.
This trial is testing a surgical approach for people with HPV-related oropharyngeal cancer that is stage I or II (but not the very smallest). The goal is to see if removing the tumor through the mouth and taking out neck lymph nodes is effective and safe. It may be an option if you are healthy enough for surgery.
This Phase 2 trial studies a robotic surgery approach for certain HPV-related throat cancers, using HPV blood tests before and after surgery to guide care. If your cancer is HPV-related and your HPV blood test results match the trial targets, you may be able to join and help improve treatment for future patients.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
Hear when a new Squamous Cell Carcinoma of Oropharynx trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.